Skip To Main Content
Şendağ Yaslıkaya on Muck Rack

Şendağ Yaslıkaya

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Şendağ

Contact Şendağ, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Impact of PIK3CA Mutations and Inflammation–Nutritional Biomarkers on Pathological Complete Response in HER2-Positive Early Breast Cancer: A Real-World Cohort Study

|
By Ibrahim Kaplan, Şuheda Ataş İpek, Şendağ Yaslıkaya
| Preprints.org
You are already at the latest version Background/Objectives: Although dual HER2-targeted neoadjuvant therapy improves pathological complete response (pCR) rates in HER2-positive early breast cancer (EBC), a substantial proportion of patients have residual disease. We evaluated the association between PIK3CA mutations, inflammation–nutritional biomarkers, and pCR.
Open in Who Shared Issue with article?
See all 1 articles